Evidence map›Paper›PMID 35183615›Full record

ArticleJournal of neuroscience methods2022

Method of long-term, recurrent, intracerebroventricular infusion of cellular therapy in mice.

Chao-Hsien Chen, Michael A Curran

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of neuroscience methods, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 60% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Chao-Hsien ChenDepartment of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Neurology, Houston Methodist Neurological Institute, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX 77030, USA.
Michael A CurranDepartment of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; UT Health Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA. Electronic address: mcurran@mdanderson.org.
Houston Methodist · USThe University of Texas MD Anderson Cancer Center · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
Reversal of neurodegeneration through pTau clearance by chimeric scavenger receptor monocytesR21AG068546 · NIA · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI CURRAN, MICHAEL A. · 2020 to 2020
$446k
NCI NIH HHS P30 CA016672NIA NIH HHS R21 AG068546
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Infusions, IntraventricularAnimalsBlood PressureInjections, IntraventricularMice

Identifiers

PMID35183615
PMCPMC8917793
OpenAlexW4213353598

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.